Founded in 1923 and headquartered just outside Denmark,
$Novo-Nordisk A/S(NVO)$ is a global healthcare company aimed at defeating serious chronic diseases like diabetes. Having a market cap of DKK $310 trillion, Novo Nordisk is the world's 12th most valuable company, even bigger than the entire Danish economy. Unlike some big pharmas who priced drugs at exorbitant prices (making you wonder if they even care about making society better or are just interested in earning profits), Novo Nordisk is committed to helping societies defeat diabetes in a responsible and affordable manner.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments